Browsing Tag

Dr Reddy’s Laboratories

DRL issues statement on receipt of warning letter from US FDA

Sanjiv Das Nov 9, 2015

The company has received warning letters for API manufacturing and oncology formulation manufacturing facilities at Andhra Pradesh…

Sanjiv Das Nov 5, 2015

DRL will aim to develop the access of the Romanian patients to the Biocodex's product portfolio Drug major Dr Reddy's…

Sanjiv Das Oct 14, 2015

DRL will be permitted to market a 505(j) generic version of Aloxi in the US on September 30, 2018 or earlier under certain…

Sanjiv Das Sep 28, 2015

The 20 mg and 40 mg capsules are available in bottle count size of 30 Dr Reddy’s Laboratories (DRL) has launched esomeprazole…

Sanjiv Das Sep 21, 2015

BioMarin will allow the Indian drug maker to market a generic version of Kuvan 100mg tablets in the US at a later stage The…

Sanjiv Das Sep 10, 2015

To market PanTheryx’s proprietary nutritional intervention for paediatric infectious diarrhoea PanTheryx, a global medical…

Sanjiv Das Aug 28, 2015

Umang Vohra was previously Dr Reddy's Laboratories's Chief Financial Officer in India Dr Reddy’s Laboratories North America head…

Usha Sharma Aug 20, 2015

A total of 60 bottles of 2952 units are recalled on the direction of US FDA

Sanjiv Das Aug 13, 2015

The tablets are available in 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg in bottle count sizes of 30 Dr Reddy’s Laboratories (DRL)…

Sanjiv Das Aug 6, 2015

DRL to market and distribute Amgen’s Repatha, Kyprolis and BLINCYTO in India upon approval Dr Reddy’s Laboratories (DRL) has…